Inhaled anti-thymic stromal lymphopoietin antibody fragment, ecleralimab, in severe asthma: A placebo-controlled, multicenter, double-blind, randomized, phase 2b clinical trial

Affiliations

• ¹ Novartis Pharma AG, Basel, Switzerland.
• ² Department of Clinical Immunology, University Hospital Leipzig, Leipzig, Germany.
• ³ POIS Leipzig GbR, Leipzig, Germany.
• ⁴ Respiratory Area of the Foundation for Clinical Assistance and Research in Prevalent Diseases (FAICEP), Buenos Aires, Argentina.
• ⁵ Allergy and Asthma Specialists Medical Group and Research Center, Huntington Beach, CA, United States.
• ⁶ Fukuwa Clinic, Tokyo, Japan.
• ⁷ Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
• ⁸ Novartis Ireland Limited, Dublin, Ireland.
• ⁹ Department of Medicine, McMaster University, Hamilton, ON, Canada.